APA

Kopelman P., Groot G. d. H., Rissanen A., Rossner S., Toubro S., Palmer R., Hallam R., Bryson A. & Hickling R. I. (20100331). Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). : Obesity (Silver Spring, Md.).

Chicago

Kopelman Peter, Groot Gerrit de H, Rissanen Aila, Rossner Stephan, Toubro Soren, Palmer Richard, Hallam Rob, Bryson Andrew and Hickling Roger I. 20100331. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). : Obesity (Silver Spring, Md.).

Harvard

Kopelman P., Groot G. d. H., Rissanen A., Rossner S., Toubro S., Palmer R., Hallam R., Bryson A. and Hickling R. I. (20100331). Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). : Obesity (Silver Spring, Md.).

MLA

Kopelman Peter, Groot Gerrit de H, Rissanen Aila, Rossner Stephan, Toubro Soren, Palmer Richard, Hallam Rob, Bryson Andrew and Hickling Roger I. Weight loss, HbA1c reduction, and tolerability of cetilistat in a randomized, placebo-controlled phase 2 trial in obese diabetics: comparison with orlistat (Xenical). : Obesity (Silver Spring, Md.). 20100331.